These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17374084)

  • 1. Inhibitors of calcification in blood and urine.
    Schlieper G; Westenfeld R; Brandenburg V; Ketteler M
    Semin Dial; 2007; 20(2):113-21. PubMed ID: 17374084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calcified coronary artery disease and serum markers].
    Mori K; Jono S
    Clin Calcium; 2007 Mar; 17(3):340-5. PubMed ID: 17339737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vascular calcification and serum markers].
    Yoshida M; Tomiyama H; Yamashina A
    Clin Calcium; 2010 Nov; 20(11):1694-9. PubMed ID: 21037390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular calcification: lessons from scientific models.
    Sinha S; Eddington H; Kalra PA
    J Ren Care; 2009 Mar; 35 Suppl 1():51-6. PubMed ID: 19222732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Can cardiovascular calcifications be prevented in chronic kidney disease?].
    Coen G; Manni M; Mantella D; Splendiani G
    G Ital Nefrol; 2006; 23 Suppl 34():S21-5. PubMed ID: 16633990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory mechanisms in vascular calcification.
    Boström K; Demer LL
    Crit Rev Eukaryot Gene Expr; 2000; 10(2):151-8. PubMed ID: 11186330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular calcification: mechanisms and clinical ramifications.
    Abedin M; Tintut Y; Demer LL
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1161-70. PubMed ID: 15155384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular calcification and uremia: what do we know?
    Cozzolino M; Mazzaferro S; Pugliese F; Brancaccio D
    Am J Nephrol; 2008; 28(2):339-46. PubMed ID: 18046081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of extraskeletal calcifications in uremia].
    Cozzolino M; Galassi A; Bellasi A; Butti A; Zoni U; Gallieni M; Brancaccio D
    G Ital Nefrol; 2005; 22 Suppl 31():S53-5. PubMed ID: 15786403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice.
    Merx MW; Schäfer C; Westenfeld R; Brandenburg V; Hidajat S; Weber C; Ketteler M; Jahnen-Dechent W
    J Am Soc Nephrol; 2005 Nov; 16(11):3357-64. PubMed ID: 16177000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification.
    Schurgers LJ; Teunissen KJ; Knapen MH; Kwaijtaal M; van Diest R; Appels A; Reutelingsperger CP; Cleutjens JP; Vermeer C
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1629-33. PubMed ID: 15961706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteogenic regulation of vascular calcification: an early perspective.
    Vattikuti R; Towler DA
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E686-96. PubMed ID: 15102615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors of atherosclerosis in end-stage renal disease patients].
    Jono S
    Clin Calcium; 2004 Jan; 14(1):21-6. PubMed ID: 15576949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetuin, matrix-Gla protein and osteopontin in calcification of renal allografts.
    Lorenzen JM; Martino F; Scheffner I; Bröcker V; Leitolf H; Haller H; Gwinner W
    PLoS One; 2012; 7(12):e52039. PubMed ID: 23284864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Origin of the mediacalcosis in kidney failure].
    Torres PA
    J Mal Vasc; 2009 May; 34(3):204-10. PubMed ID: 19345526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between fetuin-A concentration, elevated levels of inflammatory markers, and arterial wall stiffness in end-stage kidney disease.
    Kuźniar J; Porazko T; Klinger M
    J Ren Nutr; 2008 Jan; 18(1):83-6. PubMed ID: 18089450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis.
    Shroff RC; Shah V; Hiorns MP; Schoppet M; Hofbauer LC; Hawa G; Schurgers LJ; Singhal A; Merryweather I; Brogan P; Shanahan C; Deanfield J; Rees L
    Nephrol Dial Transplant; 2008 Oct; 23(10):3263-71. PubMed ID: 18463323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular calcification in chronic kidney disease: pathogenesis and clinical implications.
    Shioi A; Nishizawa Y
    J Ren Nutr; 2009 Jan; 19(1):78-81. PubMed ID: 19121777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study.
    Canfield AE; Farrington C; Dziobon MD; Boot-Handford RP; Heagerty AM; Kumar SN; Roberts IS
    J Pathol; 2002 Feb; 196(2):228-34. PubMed ID: 11793375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of arterial calcification: spotlight on the inhibitors.
    Weissen-Plenz G; Nitschke Y; Rutsch F
    Adv Clin Chem; 2008; 46():263-93. PubMed ID: 19004192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.